Imagi Picks Ibrix

Imagi Studios picks Ibrix Fusion to prime the company for rapid growth and to expand the capacity of its feature film production pipeline

May 1, 2007

1 Min Read
NetworkComputing logo in a gray background | NetworkComputing

BILLERICA, Mass. -- IBRIX Inc., the leader in scalable file serving solutions, today announced that Imagi Studios, the major global animation studio headquartered in Hong Kong, has chosen IBRIX Fusion™ to prime the company for continued rapid growth and to expand the capacity of its feature film production pipeline. On the heels of its success with the March 2007 theatrical release of TMNT (Teenage Mutant Ninja Turtles), Imagi has established aggressive plans to deliver one movie every eight months and enhance its animation technology to provide movie-goers a superior viewing experience. IBRIX Fusion, a breakthrough file serving solution, provides Imagi with the reliability and performance scalability needed to meet their goals.

Imagi’s mission is to create a slate of high-quality CG-animated feature films with superhero themes to entertain global audiences. To do so, Imagi recognized the need to ramp up its computer processing power to manage its animation rendering requirements. A single film may be comprised of hundreds of thousands of frames, each rendered digitally. The ability to quickly and efficiently deliver the files needed to build those frames is a vital factor in meeting film production schedules.

“As we embark on our next two projects, Gatchaman and Astro Boy, it is imperative we have in place a computing infrastructure that will meet the strong demands placed on our rendering application during production,” said Peter Pang, M.I.S. manager at Imagi. “We were looking for a solution capable of handling billions of data requests per day and IBRIX Fusion has demonstrated success with these requirements. With this solution in place we expect to improve our rendering and achieve our aggressive production goals.”

Ibrix Inc.

SUBSCRIBE TO OUR NEWSLETTER
Stay informed! Sign up to get expert advice and insight delivered direct to your inbox

You May Also Like


More Insights